PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CPC Clinical Research, Aurora, CO; Department of Medicine, University of Colorado, Aurora, CO. Electronic address: connie.hess@cpcmed.org.\', \'CPC Clinical Research, Aurora, CO; Department of Medicine, University of Colorado, Aurora, CO.\', \'Department of Medicine, University of Colorado, Aurora, CO; ARCA biopharma, Westminster, CO.\', \'Johannes Gutenberg University Medical Center, Mainz, Germany; Scripps Research, La Jolla, CA.\', \'CPC Clinical Research, Aurora, CO; Department of Medicine, University of Colorado, Aurora, CO; The State University of New York Downstate Health Sciences University, Brooklyn, NY.\', \'Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA.\', \'Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.\', \'ARCA biopharma, Westminster, CO.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0002-8703(21)00483-X10.1016/j.ahj.2021.12.010
?:hasPublicationType
?:journal
  • American heart journal
is ?:pmid of
?:pmid
?:pmid
  • 34986394
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.267
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34986394>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34986394>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all